These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32142054)

  • 1. An Acute Care Contingency Management Program for the Treatment of Stimulant Use Disorder: A Case Report.
    Bach P; Garrod E; Robinson K; Fairbairn N
    J Addict Med; 2020 Dec; 14(6):510-513. PubMed ID: 32142054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic.
    Zastepa E; Sun JC; Clune J; Mathew N
    J Subst Abuse Treat; 2020 Nov; 118():108102. PubMed ID: 32854983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingency Management for Stimulant Use Disorder: Progress, Challenges, and Recommendations.
    Rawson RA; Erath TG; Chalk M; Clark HW; McDaid C; Wattenberg SA; Roll JM; McDonell MG; Parent S; Freese TE
    J Ambul Care Manage; 2023 Apr-Jun 01; 46(2):152-159. PubMed ID: 36745163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulant Use Disorders.
    Park TM; Haning WF
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):461-71. PubMed ID: 27338967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection.
    Mimiaga MJ; Closson EF; Pantalone DW; Safren SA; Mitty JA
    Psychol Health Med; 2019 Mar; 24(3):374-381. PubMed ID: 30211620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant abuse treatment as HIV prevention.
    Shoptaw S; Reback CJ; Frosch DL; Rawson RA
    J Addict Dis; 1998; 17(4):19-32. PubMed ID: 9848029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contingency management: an evidence-based component of methamphetamine use disorder treatments.
    Roll JM
    Addiction; 2007 Apr; 102 Suppl 1():114-20. PubMed ID: 17493060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.
    Palis H; MacDonald S; Jun J; Oviedo-Joekes E
    Harm Reduct J; 2021 May; 18(1):57. PubMed ID: 34016137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A contingency management approach for treatment of methamphetamine use disorder and human immunodeficiency virus antiretroviral treatment adherence in pregnancy to prevent mother-to-child transmission: a case report.
    Turner S; Nader M; Lurie E
    J Med Case Rep; 2022 Apr; 16(1):165. PubMed ID: 35473945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness.
    McDonell MG; Srebnik D; Angelo F; McPherson S; Lowe JM; Sugar A; Short RA; Roll JM; Ries RK
    Am J Psychiatry; 2013 Jan; 170(1):94-101. PubMed ID: 23138961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence.
    Vocci FJ; Montoya ID
    Curr Opin Psychiatry; 2009 May; 22(3):263-8. PubMed ID: 19307968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of stimulant use disorder: A systematic review of reviews.
    Ronsley C; Nolan S; Knight R; Hayashi K; Klimas J; Walley A; Wood E; Fairbairn N
    PLoS One; 2020; 15(6):e0234809. PubMed ID: 32555667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "I's" on the prize: A systematic review of individual differences in Contingency Management treatment response.
    Forster SE; DePhilippis D; Forman SD
    J Subst Abuse Treat; 2019 May; 100():64-83. PubMed ID: 30898330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-managing illicit stimulant use: A qualitative study with patients receiving injectable opioid agonist treatment.
    Palis H; Harrison S; MacDonald S; Marsh DC; Schechter MT; Oviedo-Joekes E
    Drug Alcohol Rev; 2020 Nov; 39(7):914-923. PubMed ID: 32588514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signals of increasing co-use of stimulants and opioids from online drug forum data.
    Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
    Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of a positive affect intervention for methamphetamine users.
    Carrico AW; Gόmez W; Jain J; Shoptaw S; Discepola MV; Olem D; Lagana-Jackson J; Andrews R; Neilands TB; Dilworth SE; Evans JL; Woods WJ; Moskowitz JT
    Drug Alcohol Depend; 2018 Nov; 192():8-15. PubMed ID: 30195243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-as-usual in the methamphetamine treatment project.
    Galloway GP; Marinelli-Casey P; Stalcup J; Lord R; Christian D; Cohen J; Reiber C; Vandersloot D
    J Psychoactive Drugs; 2000; 32(2):165-75. PubMed ID: 10908004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment.
    Palis H; Marchand K; Peachey GS; Westfall J; Lock K; MacDonald S; Jun J; Bojanczyk-Shibata A; Harrison S; Marsh DC; Schechter MT; Oviedo-Joekes E
    Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):68. PubMed ID: 34530878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contingency management for the treatment of methamphetamine use disorder: A systematic review.
    Brown HD; DeFulio A
    Drug Alcohol Depend; 2020 Nov; 216():108307. PubMed ID: 33007699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.